All posts by: Michael Zand

About Michael Zand

Rare Melanomas Prove ‘Hard to Get’ Using Immunotherapy – Medscape

Continue reading

2017-03-13 NEWS

Medscape

Rare Melanomas Prove ‘Hard to Get’ Using Immunotherapy
Medscape
Hello. This is Dr Jeffrey Weber. I am a medical oncologist at the Perlmutter Cancer Center at the New York University Langone Medical Center in New York. Today we are going to be talking about the use of immunotherapy in some of the more unusual …

Continue reading

2017-03-13 NEWS

Medscape

Rare Melanomas Prove ‘Hard to Get’ Using Immunotherapy
Medscape
Hello. This is Dr Jeffrey Weber. I am a medical oncologist at the Perlmutter Cancer Center at the New York University Langone Medical Center in New York. Today we are going to be talking about the use of immunotherapy in some of the more unusual …

Continue reading

2017-03-13 NEWS

Genetic Literacy Project

Will cancer patients reap benefits of ‘breakthroughs’ in immunotherapy?
Genetic Literacy Project
When immunotherapy works, the result is terrific, even life-changing. Today, though, only a tiny minority of patients expected to die from cancer will benefit from immunotherapy. As is often the case, hype sadly exceeds evidence, creating

Continue reading

2017-03-13 NEWS

Celltex autologous stem cell case study published in Stem Cells and Development demonstrates favorable response in …
Yahoo Finance
HOUSTON, March 13, 2017 /PRNewswire/ — Houston-based biotechnology company Celltex Therapeutics Corporation announces that Stem Cells and Development has published “Autologous Adipose Stem Cell Therapy for Autonomic Nervous System …
$145.8 Million Stem Cell Therapy Market by Type, Therapeutic Application, Cell Source – Global Forecasts to 2021 …Business Wire (press release)
Stem cell therapy for the treatment of Peyronie’s disease.UroToday
Stem Cell Therapy Market Report, Analysis and Trends 2017satPRnews (press release)
WhaTech
all 6 news articles »
Continue reading

2017-03-13 NEWS

Celltex autologous stem cell case study published in Stem Cells and Development demonstrates favorable response in …
PR Newswire (press release)
Celltex Chief Scientific Officer, Dr. Jane Young, MD, PhD, is part of the research team who authored the case study focused on two pediatric rheumatoid arthritis patients who are responding favorably to autologous mesenchymal stem cell therapy using
$145.8 Million Stem Cell Therapy Market by Type, Therapeutic Application, Cell Source – Global Forecasts to 2021 …Business Wire (press release)
Stem cell therapy for the treatment of Peyronie’s disease.UroToday
Stem Cell Therapy Market Report, Analysis and Trends 2017satPRnews (press release)
WhaTech
all 6 news articles »